Skip to content
New Pipeline

New Pipeline

Candidate Name
Target Pathogen
Indication
Rights
i
Confidential
Acinetobacter baumannii CRA
Serious infections
Fully-owned
Candidate Name
Confidential
Target Pathogen
Acinetobacter baumannii CRA
Indication
Serious infections
Rights
i
Fully-owned
Preclinical Phase
Candidate Name
Target Pathogen
Indication
Rights
i
Confidential
Pseudomonas aeruginosa MDR & Staphylococcus aureus MRSA
Cystic Fibrosis
Fully-owned
Candidate Name
Confidential
Target Pathogen
Pseudomonas aeruginosa MDR & Staphylococcus aureus MRSA
Indication
Cystic Fibrosis
Rights
i
Fully-owned
Preclinical Phase
Candidate Name
Target Pathogen
Indication
Rights
i
Confidential
Enterobacteriaceae, Pseudomonas aeruginosa Acinetobacter baumannii, including cabapenem resistant strains.
Life-threatening bacteremia
Fully-owned
Candidate Name
Confidential
Target Pathogen
Enterobacteriaceae, Pseudomonas aeruginosa Acinetobacter baumannii, including cabapenem resistant strains.
Indication
Life-threatening bacteremia
Rights
i
Fully-owned
Preclinical Phase
Candidate Name
Target Pathogen
Indication
Rights
i
Confidential
Enterococcus faecium VRE
Nosocomial infections
Fully-owned
Candidate Name
Confidential
Target Pathogen
Enterococcus faecium VRE
Indication
Nosocomial infections
Rights
i
Fully-owned
Preclinical Phase
Candidate Name
Target Pathogen
Indication
Rights
i
Confidential
Acinetobacter baumannii CRA Klebsiella pneumoniae CRE & ESBL-producing
-
Fully-owned
Candidate Name
Confidential
Target Pathogen
Acinetobacter baumannii CRA Klebsiella pneumoniae CRE & ESBL-producing
Indication
-
Rights
i
Fully-owned
Preclinical Phase